1079946

Novo Nordisk Pharmaceutical Industries LP — FEI 3016799712

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 20, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)